PMcardio receives FDA Breakthrough Device Designation — read the full story
Powerful Medical
25. January 2023

Introducing: PMcardio patient management & treatment recommendations

There are roughly 30 disease-specific clinical practice guideline documents for cardiovascular diseases. Each is around 150 pages long and gets updated approximately every 2-3 years. This makes it exhaustive for physicians to keep up, especially for generalists in primary care.

With this in mind, we’ve developed one of PMcardio’s core features: Our treatment recommendations engine. Armed with this powerful feature, you’ll no longer need to worry about keeping up with the ever-changing guidelines. You will always be adherent to the most up-to-date version.

In this article, we’ll show you how our patient management recommendations (PMRs) work and what benefits they bring to your everyday practice.

How do PMcardio treatment recommendations work?

After creating an ECG diagnostic report in PMcardio, the app generates a series of ECG diagnosis-specific clinical questions for an appropriate contextual diagnosis of a patient.

An image of PMcardio app showing the screen during answering patient history questions leading to generating treatment recommendations

For each of the 38 cardiovascular diagnoses that PMcardio supports, there is a decision tree of these clinical questions constructed using the official clinical practice guidelines developed and published by the ESC (European Society of Cardiology).

By answering these questions, you navigate the pathway of the decision tree to the right course of action prescribed by the ESC guidelines.

Combining the ECG diagnostics with these patient parameters, our engine generates personalized patient management recommendations consisting of specific therapeutic strategies that the doctor must follow in each particular patient case. That includes procedures and drugs, complying with the latest drug interactions, and contraindications.

Our engine doesn’t only list the drugs, dosages, and procedures based on the guidelines but also provides information on why we made the suggestions, including warnings.*

*First-level treatment recommendations have been implemented for all diagnoses currently supported by the PMcardio platform.

Introducing: PMcardio patient management & treatment recommendations
Introducing: PMcardio patient management & treatment recommendations

Read your next ECG with AI

Be part of a future where expert ECG interpretation is smarter, faster, and more accessible. Sign up now and claim your 5 free ECG reports – no credit card needed.

What are the benefits of using PMcardio patient management recommendations?

Now, let’s explore the benefits of having these in-app treatment recommendations always handy in your phone.

1. Always adhere to the most up-to-date guidelines

Keeping up with the guidelines can get overwhelming. After all, only for cardiovascular diseases, there are roughly 4,500 pages of guideline documents!

We wanted to make your life easier. With PMcardio, you will always be compliant with the most up-to-date guidelines. For each of the 38 CVDs that PMcardio supports, you will get the correct cause of action suggested directly through the app.

Just imagine the amount of time it can save you.

2. Triage cardiac patients correctly

When it comes to triaging cardiac patients, there’s a high risk of error due to incorrect evaluation of the severity of the diagnosis.

With the app’s immediate referral recommendations and traffic-light risk-rating system, you will secure accurate patient triage and improve patient referral into secondary care.

3. Streamline patient management decisions & get a valuable second opinion

Having these patient management recommendations in your phone will speed up your patient management decision-making process.

Especially in primary care, where a generalist can often use an opinion of a cardiologist when it comes to cardiac patients. Often there is no cardiologist to consult with at hand.

With PMcardio’s treatment recommendations, you will be more confident and effective in making medical decisions about patients with CVDs. And, even without relying fully on PMcardio for patient management, it can provide an invaluable second pair of eyes.

Over to you

PMcardio’s ECG reports include treatment recommendations based on decision trees that follow the latest guidelines from the European Society of Cardiology (ESC).

By using this feature, you will receive immediate treatment suggestions according to the most up-to-date clinical practice guidelines, already at the first point of contact with the patient – right after you perform an ECG scan.

These recommendations help physicians make informed, timely decisions about patient management, which is especially crucial in cardiac care.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

Share this article

Don't miss these

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.
ACC_2025

Powerful Medical at ACC 2025: Advancing AI in Cardiovascular Care

We are excited to announce that Powerful Medical will be attending the American College of Cardiology (ACC) 2025 Conference, taking place from March 29th – 31st, 2025, in Chicago, IL, USA. Once again, we have a strong presence at the conference, with multiple papers being presented, underscoring our continued leadership in AI-driven cardiovascular diagnostics.

Join 25,000 healthcare professionals who are already taking advantage of AI